SL 0101-1

Cas No.:	77307-50-7
Chemical Name:	2-(4-Hydroxyphenyl)-3-(3-O,4-O-diacetyl-α-L-rhamnopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one
Synonyms:	SL-0101-1,SL0101-1,SL-0101,SL 0101,SL0101,SL0101 1
SMILES:	C[C@H]1C(C([C@H](C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC=C(C=C4)O)O)OC(=O)C)OC(=O)C
Formula:	C25H24O12
M.Wt:	516.453
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

SL 0101-1 is a selective inhibitor of p90 Rsk (ribosomal S6 kinase) (IC50 = 89 nM for Rsk-2). This product does not inhibit upstream kinases such as MEK, Raf and PKC. SL 0101-1 inhibits the growth of MCF-7 human breast cancer cells with no effect on the normal breast cell line. For the detailed information of SL 0101-1, the solubility of SL 0101-1 in water, the solubility of SL 0101-1 in DMSO, the solubility of SL 0101-1 in PBS buffer, the animal experiment (test) of SL 0101-1, the cell expriment (test) of SL 0101-1, the in vivo, in vitro and clinical trial test of SL 0101-1, the EC50, IC50,and affinity,of SL 0101-1, For the detailed information of SL 0101-1, the solubility of SL 0101-1 in water, the solubility of SL 0101-1 in DMSO, the solubility of SL 0101-1 in PBS buffer, the animal experiment (test) of SL 0101-1, the cell expriment (test) of SL 0101-1, the in vivo, in vitro and clinical trial test of SL 0101-1, the EC50, IC50,and affinity,of SL 0101-1, Please contact DC Chemicals.